Litigation Details for Intercept Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2020)

Intercept Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2020)

Docket		Date Filed	2020-08-28
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Maryellen Noreika
Jury Demand	None	Referred To
Patents	10,047,117; 10,052,337; 10,174,073; 9,238,673
Link to Docket	External link to docket

Details for Intercept Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-11-15	14	Complaint - Amended	expiration of U.S. Patent Nos. 9,238,673 (filed June 17, 2013) (“the ’673 patent”); 10,047,117 (filed Nov. …Paragraph IV Certification of U.S. Patent Nos. 9,238,673; 10,047,117; 10,052,337; and 10,174,073 Concerning… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…20, 2015) (“the ’117 patent”); 10,052,337 (filed Apr. 26, 2016) (“the ’337 patent”); 10,174,073 (filed…25, 2017) (“the ’073 patent”); 10,751,349 (filed Jan. 15, 2019) (“the ’349 patent”); and 10,758,549 (filed	External link to document
2020-11-15	15	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,… 28 August 2020 1:20-cv-01154 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2020-08-28	4	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2; 10,047,117 B2; 10,052,… 28 August 2020 1:20-cv-01154 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document